| Literature DB >> 26690712 |
Manisha Bhutani1,2, Baris Turkbey3, Esther Tan1, Neha Korde1,4, Mary Kwok1, Elisabet E Manasanch1,5, Nishant Tageja1, Sham Mailankody1, Mark Roschewski1, Marcia Mulquin1, Ashley Carpenter1, Elizabeth Lamping1, Alex R Minter1, Brendan M Weiss1,6, Esther Mena3, Liza Lindenberg3, Katherine R Calvo7, Irina Maric7, Saad Z Usmani2, Peter L Choyke3, Karen Kurdziel3, Ola Landgren1,4.
Abstract
The incidence and importance of bone marrow involvement and/or early bone lesions in multiple myeloma (MM) precursor diseases is largely unknown. This study prospectively compared the sensitivity of several imaging modalities in monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM) and MM. Thirty patients (10 each with MGUS, SMM and MM) were evaluated with skeletal survey, [18F]FDG-PET/CT, [18F]NaF-PET/CT and morphologic dynamic contrast enhanced (DCE)-MRI. An additional 16 SMM patients had skeletal surveys and FDG-PET/CT. Among MGUS patients, DCE-MRI found only one focal marrow abnormality; other evaluations were negative. Among 26 SMM patients, five (19%) were re-classified as MM based on lytic bone lesions on CT and six had unifocal or diffuse marrow abnormality. Among MM, marrow abnormalities were observed on FDG-PET/CT in 8/10 patients and on DCE-MRI in nine evaluable patients. Abnormal NaF uptake was observed only in MM patients with lytic lesions on CT, providing no additional clinical information.Entities:
Keywords: DCE-MRI; FDG; MGUS; NaF; PET/CT; functional imaging; multiple myeloma; smoldering myeloma
Mesh:
Substances:
Year: 2016 PMID: 26690712 PMCID: PMC5576169 DOI: 10.3109/10428194.2015.1090572
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022